Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk ...

In 2025, the number of all students enrolled in medical school reached 100,723 — a significant milestone for the future of health care. After a slight dip in recent years, overall applications rose ...

For patients with hypertension, initiating treatment with an ARB is associated with the best long-term class persistence.

Management of mitochondrial-related heart disease relies on multidisciplinary care and symptom control, as targeted gene-editing therapies are limited.

Early intensive BP control significantly reduces cardiovascular risk in older patients compared with delayed initiation of treatment.

Reaching prediabetes remission is linked to a decades-long benefit, with risk for cardiovascular death or hospitalization for HF cut in half.